These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 19212678

  • 1. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.
    Ulasov IV, Tyler MA, Zhu ZB, Han Y, He TC, Lesniak MS.
    Int J Oncol; 2009 Mar; 34(3):729-42. PubMed ID: 19212678
    [Abstract] [Full Text] [Related]

  • 2. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
    Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, Marler S, Roth J, Lesniak MS.
    Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
    Ulasov IV, Rivera AA, Sonabend AM, Rivera LB, Wang M, Zhu ZB, Lesniak MS.
    Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
    [Abstract] [Full Text] [Related]

  • 4. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV, Zhu ZB, Tyler MA, Han Y, Rivera AA, Khramtsov A, Curiel DT, Lesniak MS.
    Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
    [Abstract] [Full Text] [Related]

  • 5. Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX.
    Kaverina NV, Kadagidze ZG, Borovjagin AV, Karseladze AI, Kim CK, Lesniak MS, Miska J, Zhang P, Baryshnikova MA, Xiao T, Ornelles D, Cobbs C, Khramtsov A, Ulasov IV.
    Oncogene; 2018 Nov; 37(46):6069-6082. PubMed ID: 29991800
    [Abstract] [Full Text] [Related]

  • 6. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.
    Tong Y, You L, Liu H, Li L, Meng H, Qian Q, Qian W.
    Oncotarget; 2013 Jun; 4(6):860-74. PubMed ID: 23765161
    [Abstract] [Full Text] [Related]

  • 7. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
    Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y, Lesniak MS.
    Br J Cancer; 2009 Apr 07; 100(7):1154-64. PubMed ID: 19277041
    [Abstract] [Full Text] [Related]

  • 8. A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy.
    Nandi S, Ulasov IV, Rolle CE, Han Y, Lesniak MS.
    J Gene Med; 2009 Nov 07; 11(11):1005-11. PubMed ID: 19688792
    [Abstract] [Full Text] [Related]

  • 9. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.
    Nandi S, Ulasov IV, Tyler MA, Sugihara AQ, Molinero L, Han Y, Zhu ZB, Lesniak MS.
    Cancer Res; 2008 Jul 15; 68(14):5778-84. PubMed ID: 18632631
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.
    Ulasov IV, Shah N, Kaverina NV, Lee H, Lin B, Lieber A, Kadagidze ZG, Yoon JG, Schroeder B, Hothi P, Ghosh D, Baryshnikov AY, Cobbs CS.
    Oncotarget; 2015 Feb 28; 6(6):3977-87. PubMed ID: 25738357
    [Abstract] [Full Text] [Related]

  • 11. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct 28; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 12. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
    Van Houdt WJ, Haviv YS, Lu B, Wang M, Rivera AA, Ulasov IV, Lamfers ML, Rein D, Lesniak MS, Siegal GP, Dirven CM, Curiel DT, Zhu ZB.
    J Neurosurg; 2006 Apr 28; 104(4):583-92. PubMed ID: 16619663
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
    Thaci B, Ahmed AU, Ulasov IV, Tobias AL, Han Y, Aboody KS, Lesniak MS.
    Cancer Gene Ther; 2012 Jun 28; 19(6):431-42. PubMed ID: 22555507
    [Abstract] [Full Text] [Related]

  • 14. Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis.
    Niu TK, Cheng Y, Ren X, Yang JM.
    FEBS Lett; 2010 Aug 20; 584(16):3519-24. PubMed ID: 20638385
    [Abstract] [Full Text] [Related]

  • 15. Viruses, gene therapy and stem cells for the treatment of human glioma.
    Kyritsis AP, Sioka C, Rao JS.
    Cancer Gene Ther; 2009 Oct 20; 16(10):741-52. PubMed ID: 19644531
    [Abstract] [Full Text] [Related]

  • 16. A targeting ligand enhances infectivity and cytotoxicity of an oncolytic adenovirus in human pancreatic cancer tissues.
    Yamamoto Y, Hiraoka N, Goto N, Rin Y, Miura K, Narumi K, Uchida H, Tagawa M, Aoki K.
    J Control Release; 2014 Oct 28; 192():284-93. PubMed ID: 25108153
    [Abstract] [Full Text] [Related]

  • 17. Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.
    Zhu ZB, Makhija SK, Lu B, Wang M, Rivera AA, Kim-Park S, Ulasov IV, Zhou F, Alvarez RD, Siegal GP, Curiel DT.
    Int J Oncol; 2005 Jul 28; 27(1):237-46. PubMed ID: 15942665
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of Beclin 1 enhances apoptosis by H2O2 in glioma U251 cells].
    Kong XX, Zhang HY, Chen ZQ, Fan XF, Gong YS.
    Sheng Li Xue Bao; 2011 Jun 25; 63(3):238-44. PubMed ID: 21681342
    [Abstract] [Full Text] [Related]

  • 19. Oncolytic adenoviruses for the treatment of brain tumors.
    Gomez-Manzano C, Fueyo J.
    Curr Opin Mol Ther; 2010 Oct 25; 12(5):530-7. PubMed ID: 20886384
    [Abstract] [Full Text] [Related]

  • 20. Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.
    Zhu ZB, Makhija SK, Lu B, Wang M, Wang S, Takayama K, Siegal GP, Reynolds PN, Curiel DT.
    J Thorac Oncol; 2006 Sep 25; 1(7):701-11. PubMed ID: 17409940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.